Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
Authors
Keywords
Obesity, Hypertension, Pharmacotherapy, Obesity treatment, Medications for obesity, Phentermine, Topiramate, Topiramate ER, Lorcaserin, Naltrexone, Bupropion, Qsymia, Belviq, Contrave, Suprenza
Journal
CURRENT HYPERTENSION REPORTS
Volume 15, Issue 3, Pages 182-189
Publisher
Springer Nature
Online
2013-05-01
DOI
10.1007/s11906-013-0343-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Why do we need drugs to treat the patient with obesity?
- (2013) George A. Bray Obesity
- Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity
- (2012) R. V. Cohen et al. DIABETES CARE
- Weight Loss Prevents Urinary Incontinence in Women With Type 2 Diabetes: Results From the Look AHEAD Trial
- (2012) Suzanne Phelan et al. JOURNAL OF UROLOGY
- The FDA's Assessment of Two Drugs for Chronic Weight Management
- (2012) Eric Colman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lifestyle Change and Mobility in Obese Adults with Type 2 Diabetes
- (2012) W. Jack Rejeski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
- (2012) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
- (2012) Geltrude Mingrone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults
- (2012) David H. Winslow et al. SLEEP
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus
- (2010) ARCHIVES OF INTERNAL MEDICINE
- Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
- (2010) J. B. Redmon et al. DIABETES CARE
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes
- (2010) R. R. Rubin et al. DIABETOLOGIA
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- ECO2009 Hot Topic Abstracts
- (2010) Obesity Facts
- A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesThe Sleep AHEAD StudyEffect of Weight Loss on Obstructive Sleep Apnea
- (2009) Gary D. Foster ARCHIVES OF INTERNAL MEDICINE
- Serotonergic drugs and valvular heart disease
- (2009) Richard B Rothman et al. Expert Opinion On Drug Safety
- Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist
- (2009) Carol Addy et al. JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now